Morimoto M, Toba H, Aoyama M, Nakagawa M, et al. Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer. Clin Breast Cancer 2020 Jul 24. pii: S1526-8209(20)30178.
PMID: 32800494